Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NFI Consumer Products is a U.S. consumer healthcare company focused on over-the-counter wellness and pain-relief products sold under brands including Blue-Emu and, historically, e.p.t. The business operates in topical analgesics, health and beauty care, nutritional supplements, and select consumer medical-device categories such as home pregnancy tests. Public-facing brand materials now identify Blue-Emu as part of Kingsway Pharmaceuticals, while legal and product-label sources continue to reference Kingsway Pharmaceuticals dba NFI Consumer Products or NFI, LLC. The company appears to be a commercial-stage consumer health business rather than a drug-development biotech, with revenue generated from marketed products rather than a clinical pipeline. Its portfolio emphasizes topical creams, sprays, patches, and related OTC products for muscle and joint discomfort.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NFI.